Certified by Founder Lodge
IMU Biosciences
United Kingdom - London
START UP
1 Disclosed Funding Rounds $14,639,787
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation h
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 25 ,2024 | Series A | $14,639,787 |
Molten Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
IntelliGRC | $3,500,000 | (Mar 6, 2026)
Cyclops | $8,000,000 | (Mar 6, 2026)
NextWork | $4,450,000 | (Mar 6, 2026)
Reclaim Security | $20,000,000 | (Mar 6, 2026)
Navigara | $2,500,000 | (Mar 6, 2026)
